CYIG Purchases a New Business that Will Increase Sales of a Billion U.S. Dollars for the Company in Next 5 Years

May 5, 2017 10:00 AM

SISHUI, CHINA / ACCESSWIRE / May 5, 2017 / China YCT International Group Inc. (OTCQB: CYIG) today announced that the Company signed an agreement to purchase Acer Truncatum business from Shandong YCT Group Co. Ltd. The new business is expected to increase sales by a billion U.S. dollars for the Company in next 5 years. Acer Truncatum is a kind of maple that has 300 species worldwide. Acer Truncatum is unique in growing fruits that it can...

Read more

Abattis Announces the Official Launch of Northern Vine Laboratory

May 3, 2017 9:30 AM

VANCOUVER, BC / ACCESSWIRE / May 3, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that its subsidiary, Northern Vine Canada Inc. ("Northern Vine"), has officially launched its flagship laboratory, having completed its first successful test analysis. "I am very pleased to announce this significant milestone in our Company's development," said Robert Abenante, President and CEO of...

Read more

Abattis Signs Exclusive Distribution Agreement for Proprietary Extraction Technology

April 26, 2017 10:16 AM

VANCOUVER, BC / ACCESSWIRE / April 26, 2017 / Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that it has signed an exclusive distribution agreement, effective April 20, 2017 (the "Agreement"), with Suzhou Raybot Material Tech Corp. ("Raybot"). The Agreement allows Abattis to use Raybot's proprietary extraction technology and to exclusively sell the extraction equipment and...

Read more

Cell MedX Corp. Moves its Manufacturing to British Columbia, Canada

April 26, 2017 8:15 AM

CARSON CITY, NV / ACCESSWIRE / April 26, 2017 / Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), is pleased to announce that the Company's Canadian subsidiary has entered into a production agreement with an ISO 9001 certified manufacturing facility in Coquitlam, BC, and selected North American suppliers for sourcing essential components for its eBalance Pro device. The move is intended to allow the Company to facilitate its...

Read more

MyDx Introduces the Eco Smart Pen

April 25, 2017 9:30 AM

The Next Level of Public Safety & Transparency for the Cannabis Industry SAN DIEGO, CA / ACCESSWIRE / April 25, 2017 / MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailments it alleviates, today...

Read more

MorphoSys to Host Q1 2017 Conference Call on May 3, 2017

April 24, 2017 9:25 AM

MUNICH, GERMANY / ACCESSWIRE / April 24, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY) will publish its first three months' 2017 results on May 3, 2017 at 7:00 am CEST. At 3:00 pm CEST (2:00 pm BST, 9:00 am EDT), the Management Board of MorphoSys AG will host a public conference call and webcast to present MorphoSys's first quarter interim statement 2017 and provide further details on the Company's latest...

Read more

Alliance Bio-Products, Inc. to Present at the Planet MicroCap Showcase 2017

April 24, 2017 9:15 AM

WEST PALM BEACH, FL / ACCESSWIRE / April 24, 2017 / Alliance Bio-Products, Inc. (Bio-Products), a subsidiary of Alliance BioEnergy Plus, Inc. (OTCQB: ALLM), today announced that it will be presenting at the inaugural Planet MicroCap Showcase being held from April 26-28, 2017 at the Planet Hollywood Resort & Casino in Las Vegas, NV. Daniel de Liege, Chairman of Alliance Bio-Products, will be presenting at 11:30 a.m. PT on Thursday, April...

Read more

Kineta to Present at the Planet MicroCap Showcase 2017

April 21, 2017 8:00 AM

SEATTLE, WA / ACCESSWIRE / April 21, 2017 / Kineta, Inc., a biotechnology company focused on the development of novel immuno-therapies, today announced the company has been invited to present at the inaugural Planet MicroCap Showcase being held on April 26-28, 2017 at the Planet Hollywood Resort & Casino in Las Vegas, NV. Kineta will be presenting at 1:30 PM EDT/ 10:30 AM PDT on April 27, 2017. Rob Hedequist, President and COO, will provide...

Read more

United Cannabis Corporation Enters Strategic Partnership with Advesa to Accelerate California Expansion

April 20, 2017 12:45 PM

Flagship Lab Will Serve as Company's Primary Production and Distribution Facility to Manage Increased Demand Across California DENVER, CO / ACCESSWIRE / April 20, 2017 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that it has entered into a Strategic Partnership with Advesa, a California Corporation ("Advesa"), to serve as its flagship product manufacturing facility in California for United...

Read more

Clinical Sensors Awarded Over $1.5M in NIH Grants to Advance its Nitric Oxide Diagnostic for Sepsis Recognition and Management

April 18, 2017 7:55 AM

RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 18, 2017 / Clinical Sensors, Inc. announced today that it was awarded two Small Business Research Grants from the National Institutes of Health (NIH). Together, these grants provide over $1.5 million to support the company's continued development and demonstration of its point-of-care device that directly measures a patient's blood nitric oxide level within a few seconds. Nitric oxide is involved...

Read more

MorphoSys to Present at Upcoming Conferences

April 11, 2017 8:30 AM

PLANEGG / MUNICH, GERMANY / ACCESSWIRE / April 11, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY) will present at the following conferences: 10th Kempen Life Sciences Conference Date: April 19, 2017 Venue: Amsterdam, Netherlands Presenter: Jens Holstein, Chief Financial Officer of MorphoSys AG UBS Global Healthcare Conference Date: May 22/23, 2017 Venue: New York, NY, USA Presenter: Dr. Simon...

Read more

Abattis Bioceuticals Announces New CEO

April 10, 2017 10:10 AM

VANCOUVER, BC / ACCESSWIRE / April 10, 2017 / Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce the appointment of Robert Abenante as President and Chief Executive Officer of the Company. Mr. Abenante is a seasoned executive with extensive public company experience. Mr. Abenante is a Chartered Professional Accountant (CPA, CA) who also holds a Masters. After his tenures with...

Read more

MYDX Achieves 40,000+ Consumer-Generated Pre-Clinical Data Points Growing at 100% Year Over Year

April 7, 2017 3:40 PM

Smart Devices Solidify the Critical Need for Community Participation in Generating Big Data and Formulating Cannabis Therapeutics SAN DIEGO, CA / ACCESSWIRE / April 7, 2017 / MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for the Cannabis professional and retail consumer to correlate the chemical profile of cannabis with how it makes...

Read more

MorphoSys Nominates New Candidate for Supervisory Board

April 3, 2017 2:00 AM

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 3, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that it has published its agenda for the Company's ordinary Annual General Meeting (AGM), which will take place on Wednesday, May 17, 2017. MorphoSys's Supervisory Board has nominated Krisja Vermeylen as candidate to be elected as a new Supervisory Board member at the Company's AGM. Ms. Vermeylen will...

Read more

Vitro Biopharma Receives Funding to Expand its Stem Cell Therapies

March 29, 2017 9:30 AM

GOLDEN, CO / ACCESSWIRE / March 29, 2017 / Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro Biopharma, announced the completion of a bridge loan in the amount of $125,000 and the execution of a Memorandum of Understanding ("MOU") outlining the terms of a larger, subsequent financing to provide a total of not less than $1.7 million. Completion of the subsequent larger financing through the execution of a definitive agreement would initiate the...

Read more

Abattis: Legislation to Legalize Marijuana in Canada is Being Announced Next Month

March 27, 2017 2:09 PM

VANCOUVER, BC / ACCESSWIRE / March 27, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), and its subsidiary, Northern Vine Labs, is anticipating the Liberal government's upcoming announcement, next month (the week of April 10th), on legislation that will legalize recreational marijuana use across Canada by July 1, 2018. As reported by the CBC, Trudeau's government will follow the recommendations of a...

Read more

MorphoSys's CSO Marlies Sproll Takes Temporary Leave, Markus Enzelberger to Serve as Interim CSO

March 23, 2017 3:00 AM

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / March 23, 2017 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY), a leader in the field of therapeutic antibodies, today announced that Dr. Marlies Sproll, the Company's long-standing Chief Scientific Officer, will be on temporary leave from her CSO position for family matters as of April 15, 2017. Dr. Sproll will take leave of absence from her function as member of the Executive Board...

Read more

Vitality Biopharma to Present at The MicroCap Conference on April 4th in New York City at the Essex House

March 20, 2017 1:48 PM

LOS ANGELES, CA / ACCESSWIRE / March 20, 2017 / Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, will be presenting at this year's MicroCap Conference on April 4th in New York City at the Essex House. The MicroCap Conference is an...

Read more

Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine

March 20, 2017 11:53 AM

VANCOUVER, BC / ACCESSWIRE / March 20, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine's Science Advisory efforts. Dr. Galvez received his doctorate in Plant Physiology at the University of Alberta and is a seasoned expert in the formulation and commercialization of botanical-based products, with a focus on...

Read more

Frank E. Celli, CEO of BioHiTech Global (OTCQB: BHTG), to Present at The MicroCap Conference on April 4th at 9:00 AM ET in New York City at the Essex House

March 17, 2017 10:56 AM

NEW YORK, NY / ACCESSWIRE / March 17, 2017 / BioHiTech Global (OTCQB: BHTG) CEO, Frank E. Celli, will be a featured presenter at the MicroCap Conference on April 4th in New York City, sponsored by The Special Equities Group and Maxim Group. Management will be available for one-on-one investor meetings throughout the conference. CONFERENCE OVERVIEW AND STRUCTURE The MicroCap Conference is an exclusive event for investors who specialize in small...

Read more